Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPI 1485 in symptomatic Parkinson's disease
NCT00209508Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2002
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing GPI 1485 with Placebo (2 arms). Started Nov 2002; status: completed.
02
Drugs
GPI-1485
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00209508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209508.